12 JUN 2019 · In Episode 14 of the Revenue Execution Podcast Series, we continued our conversation with Emily Yang, VP of Worldwide Sales and Marketing at Diodes and discussed their new pricing strategy, their use of channel incentives and how Diodes treats compliance. Although these topics may not be directly related, they each have an impact on margins and revenue. By continuously making improvements in these areas, Diodes is able to grow revenues on a consistent basis.

1 JUN 2019 · In Episode 13 of the Revenue Execution Podcast Series, we continued our conversation with Emily Yang, VP of Worldwide Sales and Marketing at Diodes and discussed the importance of the strategic use of channel sales data and analytics. Emily talks about how they collect, transform, and analyze their data. We also discussed the success they've achieved with this effort.

29 MAY 2019 · In Episode 12 of the Revenue Execution Podcast Series we sat down with Emily Yang, VP of Worldwide Sales and Marketing at Diodes and discussed what it takes to continuously transform.  Emily discusses about how Diodes has achieved near constant growth over 3 decades and how they plan to continue to grow in the future.

15 MAY 2019

15 MAY 2019

11 APR 2019 · Larry discusses the need for vendors to push their channels out of the transactional mentality and into higher level application and services sales, and vendors will double down on next-gen partners and deemphasize laggards, and the long-tail of your partner organization is more expensive than most vendors realize.

15 MAR 2019 · Larry discusses the need for vendors to push partners to stretch beyond their product/services comfort zones. He goes into detail on why this is necessary for long-term growth and competitiveness in today’s market.

11 MAR 2019 · It’s been a few weeks since the Department of Health and Human Services proposed a new piece of legislation that would force pharmaceutical companies to change the way they discount their products. Check out part 3 of a 3-part podcast series featuring Model N life science industry leader Jesse Mendelsohn. Hear his perspective and advice related to safe harbor changes for prescription discounts.

1 MAR 2019 · The complexities and implications of the proposed law; “Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees” can be overwhelming. The proposed changes are far reaching, impacting pharmaceutical companies, insurers, wholesalers, retailers, benefit managers and consumers.

25 FEB 2019 · It’s been a few weeks since the Department of Health and Human Services proposed a new piece of legislation that would force pharmaceutical companies to change the way they discount their products. Check out part 1 of a 3-part podcast series featuring Model N life science industry leaders; Nate Taninecz and Jesse Mendelsohn. Hear their perspective and advice related to safe harbor changes for prescription discounts.